About EvergreenHealth Medical Center
"EvergreenHealth Medical Center Kirkland includes a 318-bed medical center and four medical specialty buildings. From our leaders and caregivers to our cafeteria staff and administrators, each EvergreenHealth employee has your best interests in mind."
Clinical Trials at EvergreenHealth Medical Center
During the past decade, EvergreenHealth Medical Center conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 27 clinical trials were completed, i.e. on
average, 135% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 12 clinical trials were completed. i.e. 150%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "EvergreenHealth Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 17 trials, followed by "University of Washington" with 4 trials
sponsored, "Brown, Theodore R., M.D., MPH" with 3 trials sponsored, "Obstetrix Medical Group" with 3 trials sponsored and "SWOG Cancer Research Network"
with 3 trials sponsored. Other sponsors include 21 different institutions and
companies that sponsored additional 26 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "EvergreenHealth Medical Center"
#1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator and "NRG Oncology" with 2 trials as a collaborator. Other collaborators include 12 different institutions and companies that were
collaborators in the rest 20 trials.
Clinical Trials Conditions at EvergreenHealth Medical Center
According to Clinical.Site data, the most researched conditions in "EvergreenHealth Medical Center" are
"Parkinson Disease" (6 trials), "Multiple Sclerosis" (4 trials), "Parkinson's Disease" (3 trials), "Stage IIA Breast Cancer AJCC v6 and v7" (3 trials) and "Stage IIB Breast Cancer AJCC v6 and v7" (3 trials). Many other conditions were trialed in "EvergreenHealth Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at EvergreenHealth Medical Center
Most popular intervention types in "EvergreenHealth Medical Center" are "Drug" (41 trials), "Other" (25 trials), "Biological" (14 trials), "Device" (4 trials) and "Radiation" (4 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (16 trials), "Placebo" (12 trials), "Quality-of-Life Assessment" (6 trials), "Bevacizumab" (5 trials) and "Cisplatin" (4 trials). Other intervention names were less common.
Clinical Trials Genders at EvergreenHealth Medical Center
The vast majority of trials in "EvergreenHealth Medical Center" are
44 trials for "All" genders, 11 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at EvergreenHealth Medical Center
Currently, there are NaN active trials in "EvergreenHealth Medical Center".
undefined are not yet recruiting,
4 are recruiting,
16 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 33 completed trials in EvergreenHealth Medical Center,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in EvergreenHealth Medical Center, 2 "Phase 1"
clinical trials were conducted, 16 "Phase 2" clinical
trials and 28 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 10 trials that are defined as “Not Applicable".
Departments of EvergreenHealth Medical Center
EvergreenHealth Medical Center has several departments that took part in Clinical trials: "Cascade Cancer Center at Evergreen Hospital Medical Center" - 37 trials, "EvergreenHealth Pain Care" - 5 trials, "EvergreenHealth Infectious Disease Service" - 4 trials, "Evergreen Diabetes & Endocrinology" - 2 trials